scholarly journals Efficient Synthetic Approaches to Uric Acid Transporter 1 Inhibitors Bearing Alkoxyl Group-Substituted Triazoles

2017 ◽  
Vol 37 (7) ◽  
pp. 1748
Author(s):  
He Tian ◽  
Jingwei Wu ◽  
Yuqiang Liu ◽  
Yafei Xie ◽  
Jianwu Wang ◽  
...  
2021 ◽  
Vol 15 (4) ◽  
pp. 536-541
Author(s):  
Xiangpei Zhao ◽  
Li Li ◽  
Chuanmei Zhong ◽  
Hongli Teng ◽  
Guodong Huang

Hyperuricemia (HUA) is a metabolic disorder of purine metabolism which leads to the increase of serum uric acid. Tongfeng Lian granule (TFLA) is a clinical empirical traditional herb prescription in China, is biobased natural product material. To study its regulatory mechanism on uric acid transporter in rats with HUA, the rat model of hyperuricemic was established by oral administration of potassium oxazinate (1.5 g/kg) and adenine (0.05 g/kg). The related indexes were detected to evaluate the uric Acid Transporter after treat with TFLA. In the results, compared with model group, the high dose TFLA can reduce the levels of Related serum biochemical indexes (*P < 0.05, **P < 0.01). TFLA could reduce the levels of URAT1, GLUT9 and increase the expression of OAT3 in kidney. In conclusion, TFLA can effectively inhibit the level of serum uric acid with hyperuricemia rats, and the possible mechanism related to TFLA inhibiting the reabsorption of uric acid by URAT1 and GLUT9, promoting the secretion of OAT3 and uric acid into urine.


Author(s):  
Xiaoying Han ◽  
Jing Yang ◽  
Dong Li ◽  
Zewei Guo

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated mortality worldwide. Although the mechanisms of HCC progression are not well understood, recent studies demonstrated the potential contribution of uric acid transporter SLC2A9 to tumor suppression. However, the roles and underlying mechanisms are still unknown. We aimed to study the roles and mechanisms of SLC2A9 in HCC. The present study showed that SLC2A9 expression was decreased in human HCC tissues and cell lines. In addition, overexpression of SLC2A9 inhibited HCC cell proliferation. SCL2A9 induced HCC cell apoptosis by inhibiting the expression of caspase 3. Our study also revealed that upregulation of SLC2A9 reduced intracellular reactive oxygen species (ROS) accumulation. Furthermore, SLC2A9 increased the mRNA and protein expression of tumor suppressor p53 in HCC cells. Probenecid inhibits SLC2A9-mediated uric acid transport, which promotes cell proliferation, inhibits cell apoptosis, induces intracellular ROS, and decreases the expression of p53 in HCC cells. Therefore, the present study demonstrated that SLC2A9 may be a novel tumor suppressor gene and a potential therapeutic target in HCC.


2017 ◽  
Vol 27 (9) ◽  
pp. 1919-1922
Author(s):  
Xintuo Yang ◽  
Xuehai Pang ◽  
Lei Fan ◽  
Xinghai Li ◽  
Yuanwei Chen
Keyword(s):  

Placenta ◽  
2014 ◽  
Vol 35 (9) ◽  
pp. A97
Author(s):  
Benjamin P. Lüscher ◽  
Michael Fine ◽  
Camilla Marini ◽  
Benjamin Clemençon ◽  
Christiane Albrecht ◽  
...  

2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e76
Author(s):  
T. Konoshita ◽  
M. Urabe ◽  
S. Kaeriyama ◽  
T. Nakaya ◽  
M. Yamada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document